Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CBIA

Canopus Biopharma (PK) (CBIA)

Canopus Biopharma Inc (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CBIA

Date	Time	Source	Headline	Symbol	Company
09/11/2023	1:04PM	Edgar (US Regulatory)	Form 1-A-W - Withdrawal of offering statement [Regulation A]	USOTC:CBIA	Canopus Biopharma Inc (PK)
08/17/2023	11:38AM	Edgar (US Regulatory)	Form 1-A POS -	USOTC:CBIA	Canopus Biopharma Inc (PK)
08/15/2023	2:49PM	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:CBIA	Canopus Biopharma Inc (PK)
08/09/2023	2:39PM	Edgar (US Regulatory)	Form 253G2 -	USOTC:CBIA	Canopus Biopharma Inc (PK)
07/24/2023	8:57AM	Edgar (US Regulatory)	Form 253G1 -	USOTC:CBIA	Canopus Biopharma Inc (PK)
07/23/2023	11:15PM	Edgar (US Regulatory)	Form QUALIF - Notice of Qualification [Regulation A]	USOTC:CBIA	Canopus Biopharma Inc (PK)
07/12/2023	9:34AM	Edgar (US Regulatory)	Form 1-A POS -	USOTC:CBIA	Canopus Biopharma Inc (PK)
05/24/2023	2:34PM	Edgar (US Regulatory)	Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)	USOTC:CBIA	Canopus Biopharma Inc (PK)
05/23/2023	11:15AM	Edgar (US Regulatory)	Reflects Information Previously Omitted From the Offering Circular in Reliance on Rule 253(b) (253g1)	USOTC:CBIA	Canopus Biopharma Inc (PK)
05/11/2023	1:08PM	Edgar (US Regulatory)	Registration a Offering Under the Securities Act of 1933 (1-a)	USOTC:CBIA	Canopus Biopharma Inc (PK)